Concepedia

Author

Chang Shu

Columbia University Irving Medical CenterORCID

Also Known As

C D Shu, C Shu, C. D. Shu, C. Shu, C.D. Shu, CHANG SHU, Chang (April) Shu, Chang Shu, Nicholas Mancuso, Shu, Chang

163

Publications

3.7K

Citations

30

H-Index

182

Concepts

All Affiliations

Columbia University Irving Medical CenterUniversität UlmRenmin Hospital of Wuhan UniversityWuhan UniversityYale University
CS

About

Chang Shu is an author at Columbia University Irving Medical Center specializing in medicine, pharmacology, and social sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

6

6

248

2

Health Sciences

4

4

93

3

Business

2

2

85

4

Arts

1

1

11

5

Education

1

1

13

Chang Shu

×

65

Publications

3.4K

Citations

30

H-Index

YearCitations

Trends in Smoking Among Adults With Mental Illness and Association Between Mental Health Treatment and Smoking Cessation

Benjamin Lê Cook, Geoff Ferris Wayne, E. Nilay Kafali,

JAMA

2014

514

Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes

Xueya Zhou, Pamela Feliciano, Chang Shu,

Nature Genetics

2022

423

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models

Trang Nguyen, Yiru Zhang, Enyuan Shang,

Journal of Clinical Investigation

2020

198

Recent ultra-rare inherited variants implicate new autism candidate risk genes

Amy B. Wilfert, Tychele N. Turner, Shwetha C. Murali,

Nature Genetics

2021

137

Highly Diastereoselective and Enantioselective Synthesis of α‐Hydroxy β‐Amino Acid Derivatives: Lewis Base Catalyzed Hydrosilylation of α‐Acetoxy β‐Enamino Esters

Yan Jiang, Xing Chen, Yongsheng Zheng,

Angewandte Chemie International Edition

2011

114

Presence of an epigenetic signature of prenatal cigarette smoke exposure in childhood

Christine Ladd‐Acosta, Chang Shu, Brian K. Lee,

Environmental Research

2015

108

A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers

Georg Karpel‐Massler, Basil A. Horst, Chang Shu,

Clinical Cancer Research

2016

82

PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD

Fresia Pareja, David MacLeod, Chang Shu,

Molecular Cancer Research

2014

80

Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma

Chiaki T. Ishida, Yiru Zhang, Elena Bianchetti,

Clinical Cancer Research

2018

78

Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses

Georg Karpel‐Massler, Chiaki Tsuge Ishida, Elena Bianchetti,

Cancer Research

2017

74

Page 1